Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
EAPCI with 5900 members has become the 2nd largest Association of the European Society of Cardiology since its foundation in 2006 and has evolved into a dynamic structure under the leadership of highly dedicated individuals.In the recently completed election, a new Board has been constituted by our members and it will be my privilege to lead the Association with the support of Michael Haude as President-Elect, Jean Fajadet as Past-President, Javier Escaned as Treasurer, Andreas Baumbach as Secretary, Patrick Serruys as Editor-in-Chief of EuroIntervention, and Petr Kala and Giulio Guagliumi as EuroPCR representatives. During the upcoming term 2014-2016 I will focus with the support of the Board on the following objectives:
Interventional cardiovascular medicine is one the most vibrant and innovative disciplines within cardiology and has contributed immensely to improve patient outcome. The Association will build on previous efforts to further excel scientific knowledge and standards in several ways
The advent of transcatheter valve interventions is one of the most important recent advances in our field and cardiology as a whole. The Association will continue to advance this subspecialty in numerous ways
The prolific development in several domains including coronary interventions, transcatheter heart valve interventions, structural heart disease interventions, neurohumoral denervation and interventional pharmacology pose an increasing responsibility to provide a common ground of knowledge and expertise. The Association will further raise educational standards by:
Inequalities in access to care particularly among female patients with acute coronary syndromes have been recognized. Moreover, minimal invasive treatments such as transcatheter heart valve interventions are particularly beneficial among female elderly patients. The Association will help to address these and other issues via the dedicated EAPCI Women Committee.
Investment in the upcoming and future interventional cardiovascular community will be a top priority to attract the most talented individuals into our subspecialty. The Association has implemented the Young Committee which will continue to develop specific initiatives such as CathGO adapted to the needs of young interventional cardiologists in training.
© 2017 European Society of Cardiology. All rights reserved